FindTrial
Sign In

NIL

Co-relating pre-operative calcitonin levels with the lymph nodal burden in Medullary Thyroid Carcinoma. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/03/106312
Enrollment
100
Registered
2026-03-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C73- Malignant neoplasm of thyroid gland

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

Head Neck Cooperative Oncology Group HNCOG
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Histologically confirmed MTC 2. Initial surgery done at TMH between 2018 2023 3. Non-metastatic disease at presentation 4. Availability of complete imaging, pathology, and biochemical data

Exclusion criteria

Exclusion criteria: 1. Presence of distant metastases at presentation 2. Surgery for recurrent/residual disease 3. Incomplete clinical, radiological, biochemical or pathological data

Design outcomes

Primary

MeasureTime frame
Co relation between disease burden and calcitoninTimepoint: Preoperatively at baseline—

Secondary

MeasureTime frame
Patterns of lymph nodal metastasis in MTCTimepoint: 12 months—

Countries

India

Contacts

Public ContactDr Vidisha Tuljapurkar

Tata Memorial Hospital

vidishavt@yahoo.com24177000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026